Full text is available at the source.
Intestinal microbiota and nonalcoholic steatohepatitis
Gut bacteria and nonalcoholic fatty liver inflammation
AI simplified
Abstract
Nonalcoholic steatohepatitis (NASH) progresses from nonalcoholic fatty liver disease (NAFLD) in 10-20% of cases.
- NASH is linked to changes in the intestinal microbiota, though study results are inconsistent.
- Dysbiosis may trigger intestinal inflammation and weaken the gut barrier.
- Microbial products can reach the liver, potentially causing inflammation and contributing to NAFLD and NASH progression.
- Unique metabolomic profiles have been identified in patients with NASH, which could serve as biomarkers.
- Specific metabolites, such as ethanol, are associated with disease progression.
AI simplified